MRC1 and cancer: As loss of MMR protein expression and/or MSI are found in most Lynch syndrome-associated cancers, these analyses can be used as screening tools to increase identification of Lynch syndrome individuals and facilitate cancer-preventive surveillance strategies for affected patients and their family members.